TY  - GEN
AU  - Toure,Offianan Andre
AU  - Valecha,Neena
AU  - Tshefu,Antoinette K
AU  - Thompson,Ricardo
AU  - Krudsood,Srivicha
AU  - Gaye,Oumar
AU  - Rao,Bappanaidu Hoigegudde Krishnamurthy
AU  - Sagara,Issaka
AU  - Bose,Tarit Kumar
AU  - Mohanty,Sanjib
AU  - Rao,Ballamudi Srinivas
AU  - Anvikar,Anupkumar R
AU  - Mwapasa,Victor
AU  - Noedl,Harald
AU  - Arora,Sudershan
AU  - Roy,Arjun
AU  - Iyer,Sunil S
AU  - Sharma,Pradeep
AU  - Saha,Nilanjan
AU  - Jalali,Rajinder K
AU  - Tiacoh,Landry
AU  - Enosse,Sonia
AU  - Tangpukdee,Noppadon
AU  - Kokolomami,Jack
AU  - Ndiaye,Jean-Louis
AU  - Rao,Deepak
AU  - Yumva,Ntamabyaliro Nsengi
AU  - Sidibe,Bouran
AU  - Mohanty,Rajesh
AU  - Jha,A C
AU  - Nyirenda,Mulinda
AU  - Starzengruber,Peter
AU  - Swoboda,Paul
TI  - A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa
SN  - 1537-6591
PY  - 2016///1213
KW  - Adolescent
KW  - Adult
KW  - Africa
KW  - epidemiology
KW  - Aged
KW  - Antimalarials
KW  - administration & dosage
KW  - Artemether
KW  - Artemisinins
KW  - Asia
KW  - Child
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Ethanolamines
KW  - Female
KW  - Fluorenes
KW  - Half-Life
KW  - Heterocyclic Compounds, 1-Ring
KW  - Humans
KW  - India
KW  - Lumefantrine
KW  - Malaria, Falciparum
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Peroxides
KW  - Plasmodium falciparum
KW  - drug effects
KW  - Quinolines
KW  - Spiro Compounds
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/cid/ciw029
ER  -